Cargo Breaking News
“About 50-60% of the global vaccines are produced in India. “Last year, the pharma industry turnover in India was about 65 billion. We exported about 28 billions of pharma,” said Chief Guest, Sandeep Prakash, IRS Chief Commissioner GST & Customs Zone, Hyderabad, at the ongoing Cold Chain Unbroken (CCUB) 2024 event in Hyderabad. He added, “In 2030, the turnover is expected to rise to 130 billion. And by 2047, the government’s intention is to take it to 450 billion. So, we are looking at almost 7.5 times increase in the next 23 years. It’s obvious that if we have to grow like this, all stakeholders will have to support the industry. And representing the government, especially from the customs side, I would begin by reiterating our commitment to supporting the industry in increasing the exports. And therefore, I understand the importance of the unbroken chain also. Because this is very important for the pharmaceutical exports.
Indian Customs took the lead. Currently, we are facilitating almost 96% of the export consignments. “
The event kickstarted with highly insightful panel discussions on topics such as Airports investing and evolving cold chain infrastructure, dangerous goods management, pharmaceutical and perishable warehousing. With experts from across the world participating in the discussions, the two-day event provided a wonderful platform to discuss ideas, strategies and solutions to build a highly resilient pharma supply chain.
